Utah People's Post

The Latest News from the Beehive State

Tuesday, May 17, 2022
Log in
  • National News
    • Female Caseworker Killed & Doctor Shot in Philadelphia
  • State News
    • Car Chase Leads to Drug Arrest
  • Tech & Science
  • Health
    • How to Prepare For Ticks Season
    • Magical Weight Loss Bean Scam
  • Sports
  • Business
You are here: Home / Health / Merck Buys Rights to Experimental Ebola Vaccine

Merck Buys Rights to Experimental Ebola Vaccine

November 24, 2014 Posted by Editor

Merck Buys Experimental Ebola Vaccine

Merck & Co., the second largest U.S. drugmaker, announced that it will buy commercial rights for an experimental Ebola vaccine developed by NewLink Genetics Corp. Merck will split the total of $50 million in two payments. First, the buyer will offer $30 million upfront. When the next stage of clinical trials will be completed in the first months of 2015, Merck will pay the remaining $20 million.

If the vaccine gets approved for sale, NewLink Genetics will receive royalties. However, this will not apply in the case of African and some low-income countries.

“Effective Ebola vaccines will be a critical component of comprehensive prevention and control measures for people at risk of Ebola virus infection and to stem future outbreaks globally,” said Dr. Julie Gerberding, president of Merck Vaccines. “Merck is committed to applying our vaccine expertise to address important global health needs and, through our collaboration with NewLink, we hope to advance the public health response to this urgent international health priority.”

According to the company, the vaccine will be made as affordable as possible, especially in low-income countries, where this year’s Ebola epidemic produced the largest number of victims so far.

Ebola killed more than 5,400 people died this year. Almost all deaths, with the exception of 15, have been recorded in the Western African countries of Guinea, Liberia and Sierra Leone.

The rVSV-EBOV vaccine was developed by the Public Health Agency of Canada, which sold the rights to NewLink, of Ames, Iowa, in 2010. Scientists used another weaker version of a virus called vesicular stomatitis to develop rVSV-EBOV. By making the virus look like Ebola to the organism, it manages to trigger an immune response to the deadly virus. The Public Health Agency of Canada will retain some noncommercial rights to rVSV-EBOV.

The Walter Reed Army Institute of Research in the U.S. is already testing the vaccine. After this stage, which involves healthy volunteers, ensures the vaccine’s safety and assesses the adequate dosage, rVSV-EBOV will enter the next trial stage.

Fortunately, if the vaccine somehow fails to demonstrate effectiveness during the extended trials, there are other vaccine candidates following a similar timeline. GlaxoSmithKline works with the National Institutes of Health to develop a vaccine against Ebola. Simultaneously, Johnson & Johnson collaborates with Bavarian Nordic of Denmark on a similar project.

Share this:

  • Tweet
  • Share on Tumblr

Filed Under: Health Tagged With: ebola experimental vaccine, ebola vaccine, Merck, NewLink, Public Health Agency of Canada, rVSV-EBOV

Woman working out at the gym

Just 23% of Americans Are Working Out Enough in Their Spare Time

June 29, 2018 By Amelia Donovan

Poliovirus Therapy Gives Brain Cancer Patients New Hope (Study)

June 29, 2018 By Amelia Donovan

United Airlines airplane

Passenger Mysteriously Dies on United Airlines flight Bound for Boston

June 28, 2018 By Amelia Donovan

Breakfast sandwich

Here Are Some Foods No Nutritionist Would Ever Eat

June 27, 2018 By Amelia Donovan

Poppy flower

UN Warns of Surge in Opium-based Drugs and Cocaine Supply

June 27, 2018 By Amelia Donovan

U.S.-Canada border

French Jogger Detained 2 Weeks for Accidentally Crossing Border

June 26, 2018 By Amelia Donovan

Plus size model

Normalizing Plus Size Could Fuel Obesity Crisis (Study)

June 25, 2018 By Amelia Donovan

Giant manta ray

Unique Manta Ray Nursery Spotted off Texas Coast

June 23, 2018 By Amelia Donovan

The rainbow flag

WHO Scraps Transgenderism from List of Mental Illnesses

June 22, 2018 By Amelia Donovan

456 People Dead at U.K. Hospital after Taking too Many Painkillers

June 21, 2018 By Amelia Donovan

Kenyan girls dancing

Kenyans Facing Poor Nutrition as Supermarket Shopping Is on the Rise

June 20, 2018 By Amelia Donovan

Pages

  • About
  • Contact
  • Privacy Policy GDPR
  • Staff
  • Terms and Conditions

Recent Posts

  • Just 23% of Americans Are Working Out Enough in Their Spare Time
  • Poliovirus Therapy Gives Brain Cancer Patients New Hope (Study)
  • Passenger Mysteriously Dies on United Airlines flight Bound for Boston
  • Here Are Some Foods No Nutritionist Would Ever Eat
  • UN Warns of Surge in Opium-based Drugs and Cocaine Supply
  • French Jogger Detained 2 Weeks for Accidentally Crossing Border
  • Normalizing Plus Size Could Fuel Obesity Crisis (Study)

Related Articles

  • Woman working out at the gym

    Just 23% of Americans Are Working Out Enough in Their Spare Time

    Jun 29, 2018
  • Poliovirus Therapy Gives Brain Cancer Patients New Hope (Study)

    Jun 29, 2018
  • Breakfast sandwich

    Here Are Some Foods No Nutritionist Would Ever Eat

    Jun 27, 2018
  • Normalizing Plus Size Could Fuel Obesity Crisis (Study)

    Jun 25, 2018
  • The rainbow flag

    WHO Scraps Transgenderism from List of Mental Illnesses

    Jun 22, 2018
  • 456 People Dead at U.K. Hospital after Taking too Many Painkillers

    Jun 21, 2018
  • Young woman affected by depression

    If You Have PTSD You Were Likely Abused as a Child

    Jun 19, 2018
  • Obese dog on a leash

    Obese Dogs Can Help Us Better Understand How Obesity Works

    Jun 18, 2018
  • Our Brains Are Craving Combinations of Fats and Carbs (Study)

    Jun 15, 2018
  • Hungry bird with beck open

    Scientists Explain Why We Get ‘Hangry’

    Jun 13, 2018

Categories

  • Business
  • Entertainment
  • Health
  • National News
  • Nature
  • Provo
  • Salt Lake News
  • Science
  • Sports
  • State News
  • Tech & Science
  • Technology
  • Uncategorized
  • West Jordan
  • West Valley City
  • World

Copyright © 2022 utahpeoplespost.com

About · Privacy Policy · Terms of Use · Site Map · Contact